Katya Ravid, D.Sc.
Katya Ravid, D.Sc., is a Professor of Medicine, Biochemistry, Biology and Health Sciences at Boston University School of Medicine (BUSM). Following doctoral studies and post-doctoral training at the Technion and then MIT, Dr. Ravid joined the BUSM faculty, where she founded in 2009 a new Evans Center for Interdisciplinary Biomedical Research. She is also the founding director of a university-wide Interdisciplinary Biomedical Research Office. Dr. Ravid has mentored tens of trainees and has developed curricula for several graduate/undergraduate courses. She has been continuously funded by NIH for impactful research focused on blood cells development, with implications for blood and cardiovascular pathology. Dr. Ravid is a Fulbright Research Scholar Awardee, an elected Fellow of the American Association for the Advancement of Science, an Established Investigator with the American Heart Association, past Chair of Gordon Research Conference, and a member of International Advisory Boards, among other honors.
About the MAS President:
The President shall discharge the usual duties of a presiding officer at all meetings of the members of the Corporation, of the Board, and of the Executive Committee. The President shall be ex-officio member of all Standing Committees, except the Nominating Committee. The President shall seek to obtain Corporate, Institutional, and Friends of the Academy members. The President shall seek affiliations with other organizations, subject to the direction of the Board. The President may explore new activities deemed advantageous to the Academy. The President shall be elected for a term of three (3) years, with the opportunity for renewal as long as the Board deems appropriate.
Margaret (Peg) Riley, Ph.D.
Margaret (Peg) Riley, Ph.D., is a Professor in the Department of Biology at the University of Massachusetts Amherst. She received her Ph.D. at Harvard University and joined the faculty at Yale University, where she remained for 15 years while developing an internationally renowned research program in antimicrobial drug discovery. Her seminal studies contributed to our understanding of the human microbiome. In 2009 Dr. Riley co-founded a biopharmaceutical company, Bacteriotix LLC, whose mission is to provide proof of concept for this new drug development paradigm, with a focus on therapeutic interventions for urinary tract and pulmonary infections. In 2009 Dr. Riley co-founded the Institute for Drug Resistance, whose mission is to facilitate novel, multidisciplinary approaches to addressing the challenge of drug resistance and created a new Gordon Research Conference on Drug Resistance. In 2007 Dr. Riley founded the Massachusetts Academy of Sciences.
About the Program Director of Engage in STEM: Reporting to the President, the Program Director of Engage in STEM will be responsible for the operational success of the program, which currently operates in multiple sites across Massachusetts. The Program Director’s primary duties are as follows: Cultivate existing relationships with school districts with the goal of ensuring sufficient space and resources, and access to student and teachers; Develop and implement strategies that will maximize the success of the program; Administer logistics of program design and implementation, including but not limited to recruiting and managing mentors, raising program funds, arranging mentor transportation, designing program evaluation protocol, and distributing, collecting, and analyzing program evaluations.
James Hamilton, Ph.D.
James Hamilton, Ph.D., graduated with a PhD degree in Chemistry from Indiana University. At Boston University he holds appointments in Physiology and Biophysics, Biomedical Engineering, and Radiology. He is the founder and director of the Center for High Field NMR and Imaging at Boston University School of Medicine, and a founding member of the Boston University Obesity Center where he strongly advocates and participates in multidisciplinary and translational research. His research is aimed at providing fundamental information for the causes and for therapy of heart disease, diabetes, obesity, and neurological diseases related to fatty acid metabolism. Dr. Hamilton has received several recent awards, including the Wallace H. Coulter Translational Partners Grant Award, the Brom and Sunstein “Ignition” Award for commercializable research, the Biophysical Society Avanti Lipid Award, and Outstanding Science Alumni Award, Juniata College.
About the Treasurer: The Treasurer shall receive all monies of the Corporation and deposit them in a bank designated by the Board. The Treasurer shall pay out budgeted monies and all bills approved by the Board or Executive Committee. All checks shall bear the Treasurer’s signature or that of the President. The Treasurer shall keep an accurate account of all receipts and disbursements for each calendar year and shall post a bond for the faithful performance of outlined duties upon such terms and in such amount as the Board may direct, paying the cost thereof from the funds of the Corporation. The fiscal year for the Treasurer’s report shall be the calendar year. The Treasurer shall be elected for a term of three (3) years, with the opportunity of renewal as long as the Board deems appropriate.
Robin MacDonald, BS, Boston University, (email@example.com)
About the Coordinator: The Coordinator shall keep a record of all meetings of the Corporation, the Board, and the Executive Committee. The Coordinator shall report to the members at the Annual Business Meeting and at such other times as the Board may direct. The Coordinator shall send out official notices of meetings and perform other necessary duties of the office. The Coordinator shall be elected for a term of three years, with the opportunity of renewal as long as the Board deems appropriate. Until the MAS reaches a critical membership number, the MAS Coordinator will work on a volunteering basis.